Results 101 to 110 of about 1,633 (196)

Performance of different nebulizers in clinical use for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC).

open access: yesPLoS ONE
ObjectiveTechnical ex-vivo comparison of commercial nebulizer nozzles used for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC).MethodsThe performance of four different commercial nebulizer nozzles (Nebulizer; HurriChemTM; MCR-4 TOPOL ...
Daniel Göhler   +3 more
doaj   +1 more source

I.l) PIPAC free papers [PDF]

open access: yesPleura and Peritoneum, 2018
openaire   +1 more source

Comparison of the therapeutic efficacy of PIPAC Oxaliplatin versusPIPAC Cisplatin-Doxorubicin: experimental study in rabbit model withgastric peritoneal metastases

open access: yes
International audienceThe advantage of administering chemotherapy intraperitoneally (IP) is supported by preclinical and pharmacokinetic data (Tsuji Y et al, Annal Oncology, 2018, Sugarbaker et al, J Gastrointest Oncol, 2021).
Bardet, Sylvia M.   +6 more
core  

Current Approaches and Emerging Strategies in the Treatment of Peritoneal Carcinomatosis. [PDF]

open access: yesInt J Mol Sci
Alyasova A   +18 more
europepmc   +1 more source

Repeated PIPAC in advanced peritoneal metastases: technical feasibility in a real-world case series. [PDF]

open access: yesJ Surg Case Rep
Caruso E   +15 more
europepmc   +1 more source

Pressurized Intraperitoneal Aerosol Chemotherapy for Platinum-Resistant Ovarian Cancer: A Systematic Review and Meta-Analysis of Clinical Outcomes. [PDF]

open access: yesJ Clin Med
Brebu D   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy